Events & Presentations : Assembly Biosciences, Inc.

Events & Presentations

Upcoming Events

More events are coming soon.

Presentations

ASMB Corporate Presentation

Archived Events

Nov 20, 2019 at 9:20 AM GMT	Jefferies London Healthcare Conference
Nov 11, 2019 at 8:30 AM EST	AASLD 2019 Boston
Sep 5, 2019 at 10:15 AM EDT	Baird’s 2019 Global Healthcare Conference
Jun 22, 2019	IASL Congress 2019, Beijing, “New Therapies to More Effectively Eliminate Viral Replication and Increase Cure Rates in CHB Patients”
Jun 5, 2019	Jefferies 2019 Healthcare Conference
Apr 15, 2019	EASL 2019 VIENNA
Nov 11, 2018	AASLD 2018, San Francisco, “Final Results of a Phase 1b 28 Day Study of ABI-H0731, a Novel Core Inhibitor, in Non-Cirrhotic Viremic Subjects with Chronic HBV”
Nov 7, 2018	5th International Workshop on HBV Cure
Jun 20, 2018	Assembly Biosciences R&D Day
Apr 12, 2018	EASL Poster Review Webcast – ABI-H0731 Interim Phase 1b Data
Apr 12, 2018	EASL 2018, Paris, France, “Interim Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM), in Healthy Volunteers and Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B”
Oct 22, 2017	AASLD 2017, Washington, DC, "Rapid Turnover of cccDNA in Chronic Hepatitis B Patients Who Have Failed Nucleoside Treatment Due to Emerging"
Oct 21, 2017	AASLD 2017, Washington, DC, "Profile of Potent Second Generation CpAMs Capable of Inhibiting the Generation of HBsAg, HBeAg, pgRNA and cccDNA in HBV Infected Cells"
Oct 21, 2017	AASLD 2017, Washington, DC, "Phase 1a Safety and Pharmacokinetics of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM) For the Treatment of Chronic HBV Infection"
Sep 25, 2017	Discovery on Target 2017, Targeting HBV, Boston, MA "Targeting HBV Core Protein to Achieve Higher Cure Rates"
Sep 5, 2017	2017 International HBV Meeting, Washington DC, "Using a Toolbox of New and Established Mechanistic Assays to Determine How Core Protein Allosteric Modifiers (CpAMs) Inhibit HBV cccDNA Production"
Feb 18, 2017	APASL 2017, Shanghai, China, "Second Wave of HBV Antivirals"
Feb 17, 2017	APASL 2017, Shanghai, China, "Dual Mechanism of Actions of Novel HBV Core Protein Allosteric Modifiers (CpAMs): Inhibiting Viral Replication and Blocking cccDNA Formation"
Nov 11, 2016	The Liver Meeting® 2016, the Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, "Blockage of HBV Virus Replication and Inhibition of cccDNA Establishment by Core Protein Allosteric Modifiers"
Sep 21, 2016	2016 International HBV Meeting, Seoul, South Korea, "Complete Blockage of HBV Virus Replication and Inhibition of cccDNA Formation by Core Protein Allosteric Modifiers"